SUPN
Supernus Pharmaceuticals
$41.08
+$0.12 (+0.29%)Oct 28, 2026
Key metrics
The numbers that frame SUPN today
- Market cap
- $2.39B
- EV / FCF
- 119.0
- Gross margin
- 88.1%
- EV / Sales
- 2.7
- ROIC
- -40.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $37.54
- 52wk High
- $59.68
Growth
Revenue and earnings trend for SUPN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SUPN
Is Supernus Pharmaceuticals a good buy?
No. Supernus Pharmaceuticals has mixed quality and weak momentum. The setup is weak overall. Growth looks poor. That could put pressure on the long-term business case. We think Supernus Pharmaceuticals is selling at a high price.
What is the market capitalization of SUPN?
Supernus Pharmaceuticals's market capitalization is $2.39B.
What is the 52-week high for SUPN stock?
The 52-week high for Supernus Pharmaceuticals is $59.68. The current close of $41.08 is 31.2% below that high.
What is the 52-week low for SUPN stock?
The 52-week low for Supernus Pharmaceuticals is $37.54. The current close of $41.08 is 9.4% above that low.
Does SUPN stock pay dividends?
Supernus Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SUPN?
Supernus Pharmaceuticals's Debt / Equity ratio is 0.03.